Tailored therapy in neurodegeneration

This piece argues for precision medicine in amyotrophic lateral sclerosis, using gene-targeted treatments and rich data to tailor care. It highlights tofersen (Qalsody) for certain genetic variants, the power of long-read genome sequencing to map genetic differences, and a plan to profile patients with full omics data to identify likely responders and ensure fair access.